The APAC peptic ulcer drugs market was worth USD 1.09 billion in 2021 and is estimated to be growing at a CAGR of 4.50%, to reach USD 1.36 billion by 2026.
A peptic ulcer is a breakage in the inner surface of the stomach or the upper part of the intestine in the gastrointestinal tract. Ulcers form when the protective wall of the intestine or stomach is broken
Several factors such as the increased prevalence of H. Pylori infections, improved diagnostic healthcare techniques, easy availability of drugs for treatment, growing demand for the use of peptic ulcer drugs over surgery, increased preference of doctors for the drugs along with the use of NSAIDS to avoid causing gastric ulcers, growing cases of Irritable Bowel Syndrome (IBS) and side effects of NSAIDs are driving the growth of the APAC peptic ulcer drugs market.
NSAIDs such as Naproxen, Ibuprofen, Aspirin, and Ketoprofen, etc. can irritate the gastrointestinal mucosa with over usage and long term usage. Many people take NSAIDs as they become addicted the instant relief and often abuse the NSAIDs due to the easy availability of OTT in pharmacies, this has greatly popularized peptic ulcer drugs, the market is expected to grow at a significant growth rate in the upcoming years.
On the other hand, low pipeline productivity and changes in drug pricing policies are expected to restrain the growth of the APAC peptic ulcer drugs market during the projected period.
This research report on the APAC peptic ulcer drugs market has been segmented and sub-segmented into the following categories:
By Drug Type:
By Ulcer Type:
APAC peptic ulcer drugs market is expected to grow fastest in the global market with a good market share by the end of 2025. China and India have accounted for 55% of the APAC peptic ulcer drug market in 2020. India is estimated to be the market for the highest number, registering a compound annual rate of 5.5% during the studied period.
The growing expansion of production and consumer consumption in China has transformed the APAC market. China is the global leader in manufacturing pharmaceutical industrial products. China is the fastest-growing consumer goods and services market. Rapid consolidation among medium and large players is expected, as the Chinese government has encouraged industry consolidation with the aim of regulating the industry and improving competitiveness across various nations. The Chinese market also focuses on innovation and investment in R&D and new product development. Other noteworthy countries like Australia, India, South Korea, and Taiwan are expected to reach $ 652.8 million collectively by 2025.
Japan will grow with an estimated CAGR of 4.9% for this analyzed period. The Japanese regional market representing a combined market size of US $ 370.3 million in 2020 will reach a projected size of US $ 450 million by the end of the analysis period.
In the APAC region, India is expected to rise high among other competitors. The growing awareness of peptic ulcers in humans is one of the emerging healthcare tips in the APAC peptic ulcer drugs market in the coming years. The growth of the Indian market can be attributed to the increasing number of geriatric patients suffering from peptic ulcers as well as increasing healthcare expenses in the country. Other factors helping this market growth are the easy availability of medicines and a variety of treatment options such as Ayurveda, homeopathy, etc. for peptic ulcers.
On the other hand, Australia will slow the sluggish growth rate in the market during the forecast period due to strict reimbursement policies.
KEY MARKET PLAYERS:
Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc., Helicure AB and Eumedica Pharmaceuticals are some of the companies currently dominating the APAC peptic ulcer drugs market and profiled in this report.
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferences
4. Market Dynamics
4.1 Impact Analysis
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.3 Regional Presence
5.2 Mergers & Acquisition Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 APAC Peptic Ulcer Drugs Market - By Drug Type:
6.1.1 Proton Pump Inhibitors (PPIs)
6.1.3 H2 Antagonists
6.1.7 Market Size Estimations & Forecasts (2021-2026)
6.1.8 Y-o-Y Growth Rate Analysis
6.1.9 Market Attractiveness Index
6.2 APAC Peptic Ulcer Drugs Market -By Ulcer Type:
6.2.1 Gastric Ulcers
6.2.2 Duodenal Ulcer
6.2.3 Esophageal Ulcer
6.2.4 Market Size Estimations & Forecasts (2021-2026)
6.2.5 Y-o-Y Growth Rate Analysis
6.2.6 Market Attractiveness Index
7. Geographical Landscape
7.1 Asia Pacific
7.1.1 By Country
18.104.22.168 South Korea
22.214.171.124 South East Asia
126.96.36.199 Australia & NZ
188.8.131.52 Rest of Asia-Pacific
7.1.2 By Drug Type:
7.1.3 By Ulcer Type:
8. Key Player Analysis
8.1 Novartis AG
8.1.1 Business Description
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 Daiichi Sankyo Company Limited
8.3 Acetelion Ltd
8.4 Boehringer Ingelheim
8.5 Sanofi S.A.
8.6 Astra Zeneca
8.7 Ranbaxy Laboratories Limited, Inc.
8.8 Takeda Pharmaceuticals Company Limited
8.9 Pfizer Inc.
8.10 Helicure AB
8.11 Eumedica Pharmaceuticals
9. Market Outlook & Investment Opportunities
List of Tables
List of Figures
Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the areas that are still untapped.
The segment-level analysis in terms of drugs type, ulcer type, and region along with market size forecasts and estimations to detect key areas of industry growth in detail.
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.
Asia Pacific peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )
Asia Pacific Proton Pump Inhibitors (PPIs) Market By Region, From 2021 to 2026 ( USD Billion )
Asia Pacific Anti-Histamines Market By Region, From 2021 to 2026 ( USD Billion )
Asia Pacific H2 Antagonists Market By Region, From 2021 to 2026 ( USD Billion )
Asia Pacific Antacids Market By Region, From 2021 to 2026 ( USD Billion )
Asia Pacific Antibiotics Market By Region, From 2021 to 2026 ( USD Billion )
Asia Pacific Others Market By Region, From 2021 to 2026 ( USD Billion )
Asia Pacific peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )
Asia Pacific Gastric Ulcers Market By Region, From 2021 to 2026 ( USD Billion )
Asia Pacific Duodenal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )
Asia Pacific Esophageal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )
Japan peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )
Japan peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )
China peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )
China peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )
India peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )
India peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )
Australia peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )
Australia peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )
South Korea peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )
South Korea peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )